RPRX
Royalty Pharma plc · Healthcare · Medical - Pharmaceuticals
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 146 | 0 | 306.62M | $17.19B | +5 | −4 |
| Q1 2026 | 148 | +6 | 297.67M | $14.26B | +10 | −5 |
| Q4 2025 | 141 | +1 | 305.31M | $11.80B | +2 | — |
| Q3 2025 | 19 | +1 | 173.40M | $6.12B | +2 | −2 |
| Q2 2025 | 16 | 0 | 158.26M | $5.71B | — | — |
| Q1 2025 | 13 | -3 | 61.13M | $1.91B | — | −3 |
| Q4 2024 | 16 | +2 | 77.30M | $1.97B | +2 | — |
| Q3 2024 | 13 | -1 | 62.78M | $1.78B | +1 | −2 |
| Q2 2024 | 14 | — | 58.59M | $1.54B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 16.35M | — | $431.22M | 0.3% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 16.35M | — | $431.22M | 0.3% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 16.35M | — | $431.22M | 0.3% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 16.35M | — | $431.22M | 0.3% | n/c | 1 | SEC ↗ |
| 5 | Viking Global Investors ✦ | 11.97M | — | $315.65M | 1.2% | n/c | 1 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 10.93M | — | $288.28M | 0.5% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 6.85M | — | $180.30M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasivo) | 6.85M | — | $180.30M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (pasivo) | 4.81M | — | $126.82M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 2.35M | — | $61.98M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 2.06M | — | $54.26M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 945.84K | — | $24.94M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 940.03K | — | $24.79M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 785.57K | — | $20.72M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 785.57K | — | $20.72M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 785.57K | — | $20.72M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 785.57K | — | $20.72M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 270.45K | — | $7.13M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 238.99K | — | $6.30M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 57.40K | — | $1.51M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Wellington Management ✦ | 57.40K | — | $1.51M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 57.40K | — | $1.51M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 33.61K | — | $886,348 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 583 tenedores, 354.58M acciones, $16.55B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 100.00K acc. · $6.00M
Officer · 9.23K acc. · $540,752
Officer · 1.77K acc. · $104,799
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
18.7% de clase · Ver presentación original ante la SEC ↗
4.8% de clase · Ver presentación original ante la SEC ↗